JP2008546399A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008546399A5 JP2008546399A5 JP2008517535A JP2008517535A JP2008546399A5 JP 2008546399 A5 JP2008546399 A5 JP 2008546399A5 JP 2008517535 A JP2008517535 A JP 2008517535A JP 2008517535 A JP2008517535 A JP 2008517535A JP 2008546399 A5 JP2008546399 A5 JP 2008546399A5
- Authority
- JP
- Japan
- Prior art keywords
- alphavirus
- sequence
- salmonid
- oligonucleotide
- recombinant dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000710929 Alphavirus Species 0.000 claims description 21
- 241000277331 Salmonidae Species 0.000 claims description 12
- 108020004511 Recombinant DNA Proteins 0.000 claims description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 9
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 7
- 101710172711 Structural protein Proteins 0.000 claims description 5
- 239000002299 complementary DNA Substances 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 3
- 229960005486 vaccine Drugs 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 239000002773 nucleotide Substances 0.000 claims 6
- 125000003729 nucleotide group Chemical group 0.000 claims 6
- 230000002238 attenuated effect Effects 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 3
- 238000012258 culturing Methods 0.000 claims 2
- 230000002068 genetic effect Effects 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 241001507086 salmonid fish Species 0.000 claims 2
- 125000006850 spacer group Chemical group 0.000 claims 2
- 238000004806 packaging method and process Methods 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 241000700605 Viruses Species 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 241000713869 Moloney murine leukemia virus Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 241000714474 Rous sarcoma virus Species 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0506275 | 2005-06-21 | ||
| FR0506275A FR2887259B1 (fr) | 2005-06-21 | 2005-06-21 | CONSTRUCTION D'ADNc D'ALPHAVIRUS DE SALMONIDES |
| PCT/FR2006/001405 WO2006136704A2 (fr) | 2005-06-21 | 2006-06-21 | Construction d'adnc d'alphavirus de salmonides. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008546399A JP2008546399A (ja) | 2008-12-25 |
| JP2008546399A5 true JP2008546399A5 (https=) | 2013-04-25 |
| JP5284086B2 JP5284086B2 (ja) | 2013-09-11 |
Family
ID=35809739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517535A Active JP5284086B2 (ja) | 2005-06-21 | 2006-06-21 | サケ科魚類のアルファウイルスのｃＤＮＡ構築物 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8603491B2 (https=) |
| EP (1) | EP1907535B1 (https=) |
| JP (1) | JP5284086B2 (https=) |
| AU (1) | AU2006260796B2 (https=) |
| CA (1) | CA2612362C (https=) |
| DK (1) | DK177330B1 (https=) |
| FR (1) | FR2887259B1 (https=) |
| NO (1) | NO342179B1 (https=) |
| WO (1) | WO2006136704A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2887259B1 (fr) * | 2005-06-21 | 2007-09-14 | Agronomique Inst Nat Rech | CONSTRUCTION D'ADNc D'ALPHAVIRUS DE SALMONIDES |
| CL2015002907A1 (es) * | 2015-09-29 | 2016-06-17 | Univ Santiago Chile | Vacuna oral contra isav que comprende nanopartículas de quitosán que encapsulan una virina del virus isa y nanoparticulas de quitosán que encapsulan un adyuvante que consiste en un adn que se codifica para la replicasa/transcriptasa de un alfavirus de salmón (replicón), proceso de preparación, método para tratar peces infectados con isav y método para estimular la respuesta inmune en peces. |
| JP2019511255A (ja) | 2016-01-11 | 2019-04-25 | バーンダリ，インク． | マイクロニードル組成物およびそれを使用する方法 |
| NO344938B1 (en) * | 2018-12-13 | 2020-07-20 | Patogen As | Pancreas Disease Virus Markers |
| EP3693465A1 (en) * | 2019-02-05 | 2020-08-12 | Pharmaq AS | Novel fish coronavirus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994001549A1 (fr) * | 1992-07-02 | 1994-01-20 | Sankyo Company, Limited | Ribozyme bouclee en epingle a cheveux |
| SE9401091D0 (sv) * | 1994-03-31 | 1994-03-31 | Bioption Ab | Alphavirus cDNA vectors |
| CA2303768C (en) * | 1997-09-19 | 2009-11-24 | The Trustees Of The University Of Pennsylvania | Methods and vector constructs useful for production of recombinant aav |
| EP1075523B1 (en) * | 1998-05-08 | 2007-08-08 | Intervet International BV | Structural proteins of fish pancreatic disease virus and uses thereof |
| MXPA03001680A (es) * | 2000-08-29 | 2004-11-01 | Wyeth Corp | Empaque de particulas de un replicon del virus de acido ribonucleico (arn) de hebra positiva. |
| EP1540004A4 (en) * | 2002-07-31 | 2007-10-03 | Nucleonics Inc | DOUBLE-STRING RNA STRUCTURES AND CONSTRUCTS AND METHOD FOR THE PRODUCTION AND USE THEREOF |
| FR2887259B1 (fr) * | 2005-06-21 | 2007-09-14 | Agronomique Inst Nat Rech | CONSTRUCTION D'ADNc D'ALPHAVIRUS DE SALMONIDES |
-
2005
- 2005-06-21 FR FR0506275A patent/FR2887259B1/fr not_active Expired - Lifetime
-
2006
- 2006-06-15 DK DKPA200600811A patent/DK177330B1/da active
- 2006-06-21 US US11/993,676 patent/US8603491B2/en active Active
- 2006-06-21 AU AU2006260796A patent/AU2006260796B2/en active Active
- 2006-06-21 WO PCT/FR2006/001405 patent/WO2006136704A2/fr not_active Ceased
- 2006-06-21 EP EP06778633A patent/EP1907535B1/fr active Active
- 2006-06-21 CA CA2612362A patent/CA2612362C/fr active Active
- 2006-06-21 JP JP2008517535A patent/JP5284086B2/ja active Active
-
2007
- 2007-12-17 NO NO20076452A patent/NO342179B1/no unknown
-
2010
- 2010-07-01 US US12/828,739 patent/US20110064767A1/en not_active Abandoned
-
2013
- 2013-10-18 US US14/057,328 patent/US9611300B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Curtis et al. | Heterologous gene expression from transmissible gastroenteritis virus replicon particles | |
| Varnavski et al. | Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors | |
| Schelle et al. | Selective replication of coronavirus genomes that express nucleocapsid protein | |
| Willemsen et al. | On the stability of sequences inserted into viral genomes | |
| Flick et al. | Rescue of Hantaan virus minigenomes | |
| Schwarz et al. | Rescue of the 1947 Zika virus prototype strain with a cytomegalovirus promoter-driven cDNA clone | |
| Petrakova et al. | Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells | |
| Khromykh et al. | Encapsidation of the flavivirus Kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans | |
| García-Arriaza et al. | Evolutionary transition toward defective RNAs that are infectious by complementation | |
| Gehrke et al. | Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line | |
| Anraku et al. | Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity | |
| Huang et al. | Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs | |
| Tan et al. | Enterovirus A71 DNA-launched infectious clone as a robust reverse genetic tool | |
| JP2018534937A5 (https=) | ||
| Flick et al. | Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments | |
| Morley et al. | Chikungunya virus evolution following a large 3′ UTR deletion results in host-specific molecular changes in protein-coding regions | |
| Thiel et al. | Multigene RNA vector based on coronavirus transcription | |
| Liu et al. | An optimized circular polymerase extension reaction-based method for functional analysis of SARS-CoV-2 | |
| Tzeng et al. | Complementation of a deletion in the rubella virus p150 nonstructural protein by the viral capsid protein | |
| CN107532180A (zh) | 用于获得病毒颗粒的质粒和方法 | |
| Kim et al. | Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype | |
| Lee et al. | Generation of full-length infectious cDNA clones of middle east respiratory syndrome coronavirus | |
| CN104911152B (zh) | 一株重组传染性造血器官坏死病毒rIHNV HLJ‑09株及其构建方法和应用 | |
| JP2008546399A5 (https=) | ||
| Shen et al. | Towards construction of viral vectors based on avian coronavirus infectious bronchitis virus for gene delivery and vaccine development |